WinstonWınston
Back
Nordhealth AS logo

Nordhealth AS

NORDH.OL
15
Medical - Healthcare Information Services · Healthcare
Exchange
Oslo Stock Exchange
Winston Score
15
Winston is worried
Weak fundamentals across most pillars.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Weak
Growth
Mixed
Cash Flow
Weak
Stability
Data not available
Valuation
Data not available

Winston Score History

The full picture

Nordhealth AS is a Nordic software company that builds digital tools for healthcare providers. Its main products are practice management and clinical software platforms used by veterinary clinics and human healthcare clinics — helping staff book appointments, manage patient records, and handle billing. The company operates primarily across the Nordic countries, with a growing presence in other European markets.

Nordhealth makes money by charging clinics recurring subscription fees for its software, which creates a relatively predictable revenue stream. With a gross margin near 60%, the underlying software business is reasonably profitable at the product level, but the company is still spending heavily on growth, resulting in significant operating losses. Its competitive position relies on deep integration into clinic workflows, which makes switching to a rival system costly and disruptive for customers — a common moat in vertical software. The key risk is that reaching profitability depends on growing its customer base fast enough to cover its high operating costs, and competition from larger health-tech players could slow that progress.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+7.5% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

-22.1% YoY

YoY Growth Rate

Earnings declining

Insider Activity

5.6%ownership

Flat

Insider ownership roughly steady over the past year

Cash Runway

~16 months

kr 13M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Adequate runway but may need to raise capital within 2 years

Growth context

Nordhealth AS is growing revenue at 8% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
0.6%
Thin — 0.6% gross margin
Profit after running costs
Operating Margin
-25.6%
Losing money on operations — -25.6%
Return on the money invested
ROCE
-27.4%
Weak — -27.4% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+8.3%
Steady sales growth (+8.3% YoY)
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
2/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
N/A
Data not available
Spare cash per sale
FCF Margin
-13.8%
Burning cash (-13.8%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
N/A
Data not available
Covers its interest
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
N/M
no trend
Negative earnings — P/E not meaningful
Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial